NYSE · Biotechnology
Alto Neuroscience, Inc. (ANRO)
$25.37
-4.30%
52
In band
Moving averages
SMA 200$24.59+3.17%
Company profile
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company that engages in the psychiatry drug development business. The company is headquartered in Los Altos, California.
SectorHealthcare
IndustryBiotechnology
Market cap$1.23B
P/E ratioNone
EPS$-2.32
Beta1.446
Dividend yield0.00%
52-week high$37.48
52-week low$12.51
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
GHRS
GH Research PLC
RSI 41
GPCR
Structure Therapeutics Inc
RSI 25
NTLA
Intellia Therapeutics Inc
RSI 37
NVAX
Novavax Inc
RSI 33
SRPT
Sarepta Therapeutics Inc
RSI 29
ARDX
Ardelyx Inc
RSI 46
RSI alerts for ANRO
An email when ANRO closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 6:28 AM EST